Atypical metabolite levels at birth may increase SIDS risk

Newborns who had an atypical pattern of metabolites were more than 14 times as likely to die of sudden infant death syndrome (SIDS), compared to infants who had more typical metabolic patterns, according to a study funded in part by the National Institutes of Health.

Atypical metabolite levels at birth may increase SIDS risk. Photo: Christian Bowen/Unsplash

Metabolites are molecules produced by the body’s various chemical reactions. Researchers found that infants who died of SIDS had a specific pattern of metabolites compared to infants who lived to their first year.

The researchers believe that checking for this pattern could provide a way to identify infants at risk for SIDS. The study was conducted by Scott Oltman, M.S., of the University of California San Francisco School of Medicine, and colleagues.

SIDS is the sudden, unexplained death of an infant younger than 1 year of age that remains unexplained after a complete investigation.​

From more than 2 million infants born in California, researchers compared newborn screening test results of 354 SIDS cases to those of 1,416 infants who survived to at least one year old.

The state screens all its newborns for many serious disorders. Test results include checking for metabolites that are markers for disorders and conditions.

In the study, infants identified with the highest risk metabolic profile involving eight metabolites were 14.4 times more likely to have SIDS than infants with the lowest risk metabolic profile.

The authors say that testing for metabolic patterns may provide a way to identify infants at risk for SIDS soon after birth, which could inform efforts to reduce SIDS risk.

Similarly, research on the biochemical pathways that produce the metabolites linked to SIDS may yield insights into the causes of SIDS and ways to reduce its risk.

YOU MAY ALSO LIKE

One in Eight Dementia Diagnoses May Be Linked to Liver Disease

A new study indicates that up to 12.8% of individuals diagnosed with dementia might actually be suffering from cognitive symptoms caused by hepatic encephalopathy, a treatable condition related to liver cirrhosis

Seaweed May Slow Parkinson's Disease Progression

A 2024 study indicates that the consumption of the seaweed Ecklonia cava could potentially slow down or prevent Parkinson's disease, offering hope for new dietary approaches to managing the condition.

Single blood test predicts 30-year cardiovascular disease risks for women

Measuring inflammation and lipids in midlife may support earlier detection, treatment.

Process by which COVID-19 latches onto and enters human cells is revealed

New research shows the actual shape-changing sequence that allows coronavirus proteins to fuse with human cells.

New imaging method detects fungal infections caused by Aspergillus fumigatus sooner

Researchers at the National Institutes of Health’s Clinical Center and the National Heart, Lung and Blood Institute have developed and tested a new imaging method that will allow specific detection of Aspergillus fumigatus fungal infections in a timely manner in the future, without the need for invasive procedures.

Olive Oil's Role in Vegan Diets for Heart Disease Risk under Scrutiny

A new study suggests that while plant-based diets can benefit those at risk of heart disease, the addition of extra virgin olive oil (EVOO) may influence cholesterol levels in unexpected ways.